<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (AST≤37 IU/L, N = 132).</p
AbstractBackground/PurposeLiver biopsy is the gold standard to determine the severity of hepatic fib...
Liver disease is frequently asymptomatic, challenging early identification in the primary care setti...
Background/Purpose: Liver biopsy is the gold standard to determine the severity of hepatic fibrosis ...
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (AST>148 IU/L, N = 346).</p
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Moderate to severe necroin...
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Minimal-mild necroinflamma...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
<div><p>Background and aim</p><p>The aspartate aminotransferase (AST)-to-platelet ratio index (APRI)...
<p>APRI, aspartate aminotransferase-to-platelet ratio index; AUROC, area under the receiver operatin...
ObjectiveTo evaluate the diagnostic value of liver stiffness(LS) combined with aspartate aminotransf...
BACKGROUND AND AIM:The aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-...
Background: Non-invasive test have been constructed and evaluated mainly for binary diagnoses. The a...
Noninvasive markers of liver fibrosis have been most extensively studied. The aim of this study was ...
Abstract Low cut-off of FIB-4 is a widely used formula to exclude advanced liver fibrosis in primary...
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 11-15...
AbstractBackground/PurposeLiver biopsy is the gold standard to determine the severity of hepatic fib...
Liver disease is frequently asymptomatic, challenging early identification in the primary care setti...
Background/Purpose: Liver biopsy is the gold standard to determine the severity of hepatic fibrosis ...
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (AST>148 IU/L, N = 346).</p
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Moderate to severe necroin...
<p>Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Minimal-mild necroinflamma...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
<div><p>Background and aim</p><p>The aspartate aminotransferase (AST)-to-platelet ratio index (APRI)...
<p>APRI, aspartate aminotransferase-to-platelet ratio index; AUROC, area under the receiver operatin...
ObjectiveTo evaluate the diagnostic value of liver stiffness(LS) combined with aspartate aminotransf...
BACKGROUND AND AIM:The aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-...
Background: Non-invasive test have been constructed and evaluated mainly for binary diagnoses. The a...
Noninvasive markers of liver fibrosis have been most extensively studied. The aim of this study was ...
Abstract Low cut-off of FIB-4 is a widely used formula to exclude advanced liver fibrosis in primary...
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 11-15...
AbstractBackground/PurposeLiver biopsy is the gold standard to determine the severity of hepatic fib...
Liver disease is frequently asymptomatic, challenging early identification in the primary care setti...
Background/Purpose: Liver biopsy is the gold standard to determine the severity of hepatic fibrosis ...
DOI
Add to ORKG